2
May
GreenMark Biomedical Taps into MGCS and Other Resources to Accelerate its Growth
An entrepreneur’s pathway is often strewn with knotty challenges that need quick, nimble solutions, says serial entrepreneur Steven Bloembergen, chairman and CEO of GreenMark Biomedical. “I liken starting a new company to childbirth,” he explains. “It’s exciting but often painful. You cannot afford to rest on your laurels and think... Read More
2
May
Genomenon Ratchets Up its Partnerships, Revenue Stream and Venture Fundraising
All systems are go at Genomenon, a software-as-a-service company spun out of the University of Michigan in 2014 that offers products designed to improve the efficiency and accuracy of genomic-sequence analysis. “The company is doing phenomenally well,” reports CEO Mike Klein, who joined Genomenon in August 2016. “Our sales pipeline,... Read More
2
May
Cleveland Clinic Ventures Returns to 2018 MGCS with a New Cohort of Biomedical Tech Startups
This year’s Michigan Growth Capital Symposium on May 15 and 16 will be something of a homecoming for Michigan alumnus Jack Miner as well as an opportunity to show off a new cohort of emerging biomedical technology companies spun out of Cleveland Clinic. “Getting out of our network in Cleveland... Read More